📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: MDxHealth

1.1 - Company Overview

MDxHealth Logo

MDxHealth

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of molecular diagnostics and epigenetic tests for cancer assessment and personalized treatment, including Select mdx (urine test to identify men at risk for aggressive prostate cancer before an initial biopsy), Confirm mdx (tissue test for risk of undetected clinically significant prostate cancer after a negative biopsy), Genomic Prostate Score (predicts disease aggressiveness), and Resolve mdx (PCR UTI test with personalized antibiotic options).

Products and services

  • Confirm mdx: A tissue-based test that improves identification of men at risk for undetected, clinically significant prostate cancer after a negative biopsy
  • Genomic Prostate Score (GPS): A genomic assay for men with localized prostate cancer that predicts disease aggressiveness to guide treatment decisions
  • Select mdx: A urine-based test that helps identify men at risk for aggressive prostate cancer before an initial biopsy

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to MDxHealth

Progenics Pharmaceuticals Logo

Progenics Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical therapeutics for cancer and related conditions, developing PSMA-targeted radioligand therapies (PNT2002, LNTH-1095), diagnostic imaging agents (LNTH-1404), and antibodies (PSMA-TAC), plus a somatostatin receptor-targeted radioligand therapy (PNT2003) for neuroendocrine tumors, alongside pipeline candidates such as PSMA ADC and LNTH-1558 in various clinical and preclinical stages.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Progenics Pharmaceuticals company profile →
VisionGate Logo

VisionGate

HQ: United States Website
  • Description: Provider of an automated 3D cell imaging platform for early cancer detection and prevention.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full VisionGate company profile →
Adaptimmune Logo

Adaptimmune

HQ: United Kingdom Website
  • Description: Provider of T-cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases, including afami-cel, a single-dose T-cell therapy targeting cancer, and lete-cel, a single-dose T-cell therapy in development for treating solid tumors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Adaptimmune company profile →
Heidelberg Pharma Logo

Heidelberg Pharma

HQ: Germany Website
  • Description: Provider of pre-clinical drug discovery and development services for anti-cancer and anti-inflammatory drugs to pharmaceutical and biotechnology industries, including explorative pharmacology, drug metabolism and pharmacokinetics analysis, and molecular biology. Also researches, produces, and clinically develops Antibody Amanitin Conjugates (ATACs) using amanitin for cancer therapies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Heidelberg Pharma company profile →
MTM Laboratories Logo

MTM Laboratories

HQ: Germany Website
  • Description: Provider of ISO 9001 and 13485 certified in-vitro diagnostics for early detection and diagnosis of cervical and other cancers; headquartered in Heidelberg, Germany, with subsidiaries in the United States, France, Italy and Spain; markets proprietary CINtec Histology Kit and CINtec.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MTM Laboratories company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for MDxHealth

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to MDxHealth

2.2 - Growth funds investing in similar companies to MDxHealth

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for MDxHealth

4.2 - Public trading comparable groups for MDxHealth

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to MDxHealth

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About MDxHealth

What does MDxHealth do?

MDxHealth is a provider of molecular diagnostics and epigenetic tests for cancer assessment and personalized treatment, including Select mdx (urine test to identify men at risk for aggressive prostate cancer before an initial biopsy), Confirm mdx (tissue test for risk of undetected clinically significant prostate cancer after a negative biopsy), Genomic Prostate Score (predicts disease aggressiveness), and Resolve mdx (PCR UTI test with personalized antibiotic options).

Who are MDxHealth's competitors?

MDxHealth's competitors and similar companies include Progenics Pharmaceuticals, VisionGate, Adaptimmune, Heidelberg Pharma, and MTM Laboratories.

Where is MDxHealth headquartered?

MDxHealth is headquartered in United States.

How many employees does MDxHealth have?

MDxHealth has 1,000 employees 🔒.

When was MDxHealth founded?

MDxHealth was founded in 2010 🔒.

What sector and industry vertical is MDxHealth in?

MDxHealth is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for MDxHealth

Who are the top strategic acquirers in MDxHealth's sector and industry

Top strategic M&A buyers and acquirers in MDxHealth's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for MDxHealth?

Top strategic M&A buyers groups and sectors for MDxHealth include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in MDxHealth's sector and industry vertical

Which are the top PE firms investing in MDxHealth's sector and industry vertical?

Top PE firms investing in MDxHealth's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in MDxHealth's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in MDxHealth's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in MDxHealth's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to MDxHealth include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in MDxHealth's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for MDxHealth?

The key public trading comparables and valuation benchmarks for MDxHealth include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for MDxHealth for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for MDxHealth with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in MDxHealth's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for MDxHealth with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in MDxHealth's' sector and industry vertical?

Access recent funding rounds and capital raises in MDxHealth's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for MDxHealth